Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06518122
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-18
Brief Title:
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306 RLD2302 and RLD2102 in Healthy Volunteers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Open Label Multiple Dose Crossover Clinical Trial to Evaluate the Drug-drug Interaction and Safety Between HCP1306 RLD2302 and RLD2102 in Healthy Volunteers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the drug-drug interaction and safety between HCP1306 RLD2302 and RLD2102 in healthy volunteers
Detailed Description:
PART A To evaluate the drug-drug interaction and safety between HCP1306 RLD2302
PART B To evaluate the drug-drug interaction and safety between HCP1306 RLD2302 RLD2102
PART B To evaluate the drug-drug interaction and safety between HCP1306 RLD2302 RLD2102
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None